HDAC-IN-40 structure
|
Common Name | HDAC-IN-40 | ||
---|---|---|---|---|
CAS Number | 2463198-51-6 | Molecular Weight | 326.34 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C15H22N2O6 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of HDAC-IN-40HDAC-IN-40 is a potent alkoxyamide-based HDAC inhibitor with Ki values of 60 nM and 30 nM for HDAC2 and HDAC6, respectively. HDAC-IN-40 had antitumor effects[1]. |
Name | HDAC-IN-40 |
---|
Description | HDAC-IN-40 is a potent alkoxyamide-based HDAC inhibitor with Ki values of 60 nM and 30 nM for HDAC2 and HDAC6, respectively. HDAC-IN-40 had antitumor effects[1]. |
---|---|
Related Catalog | |
Target |
HDAC2:60 nM (Ki) HDAC6:30 nM (Ki) HDAC4:49200 μM (Ki) HDAC8:5690 nM (Ki) |
In Vitro | HDAC-IN-40 (Compound 13d) shows antiproliferative activity against the cell line A2780 and Cal27 with IC50 values of 0.89 µM and 0.72 µM, respectively[1]. HDAC-IN-40 induces accumulation of acetyl α-tubulin in Cal27 and Cal27CisR[1]. HDAC-IN-40 enhances the Cisplatin-induced cytotoxicity via caspase-3/7 activation[1]. |
References |
Molecular Formula | C15H22N2O6 |
---|---|
Molecular Weight | 326.34 |